C. trachomatis Antibody (Chlam. III): sc-69709

C. trachomatis Antibody (Chlam. III) is a mouse monoclonal IgG3 antibody that detects Chlamydia trachomatis across various serotypes including A, B, Ba, C, D, E, F, G, H, I, J, K, L2, and L3, by immunofluorescence (IF) and immunohistochemistry with paraffin-embedded sections (IHCP). C. trachomatis (Chlam. III) monoclonal antibody is available in a non-conjugated form, specifically designed for researchers studying the pathogenic mechanisms of Chlamydia trachomatis, a bacterium responsible for several significant human diseases. Chlamydia trachomatis is crucial for understanding the organism′s ability to invade host cells and evade the immune response, as C. trachomatis forms intracytoplasmic inclusions that can disrupt normal cellular functions. These inclusions are typically located around the infected nucleus, highlighting the bacterium′s intracellular lifestyle and reliance on host cellular machinery for replication. The genome of Chlamydia trachomatis, which ranges from approximately 500 to 1000 kilobases, encodes both RNA and DNA, allowing C. trachomatis to adapt and survive within the host environment. With 15 distinct serotypes, this pathogen is responsible for a range of diseases, including endemic trachoma, sexually transmitted infections, and lymphogranuloma venereum, making C. trachomatis a significant public health concern. Chlamydia trachomatis can infect the cervix and fallopian tubes in women, as well as the urethra in men, underscoring C. trachomatis′s role as one of the leading causes of sexually transmitted infections globally. Most strains of Chlamydia trachomatis are recognized by monoclonal antibodies targeting epitopes in the variable region 4 of the major outer membrane protein, which is essential for the bacterium′s virulence and interaction with host cells.